Targeting kidney scarring in older adults with chronic kidney disease using CAR-T cell therapy
Directly targeting renal fibrosis in the aged with CKD using in vivo CAR-T cell therapy
['FUNDING_R21'] · INDIANA UNIVERSITY INDIANAPOLIS · NIH-10951799
This study is exploring a new way to help older adults with chronic kidney disease by using a special treatment called CAR-T cell therapy that targets kidney damage, with the hope of reducing inflammation and improving kidney function.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | INDIANA UNIVERSITY INDIANAPOLIS (nih funded) |
| Locations | 1 site (INDIANAPOLIS, UNITED STATES) |
| Trial ID | NIH-10951799 on ClinicalTrials.gov |
What this research studies
This research investigates a novel approach to treat chronic kidney disease (CKD) in older adults by using CAR-T cell therapy to directly target kidney fibrosis. The study aims to understand how this therapy can reduce inflammation and improve kidney function by modifying the immune response. Patients will receive CAR-T cells designed to specifically attack fibrotic tissue in the kidneys, potentially reversing damage caused by CKD. The research will involve clinical trials to assess the safety and effectiveness of this innovative treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults aged 21 and above who are suffering from chronic kidney disease and experiencing kidney fibrosis.
Not a fit: Patients with early-stage chronic kidney disease or those without significant fibrosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a groundbreaking treatment that significantly improves kidney function and quality of life for patients with chronic kidney disease.
How similar studies have performed: While CAR-T cell therapy has shown promise in treating certain cancers, its application in targeting kidney fibrosis is novel and has not been extensively tested in clinical settings.
Where this research is happening
INDIANAPOLIS, UNITED STATES
- INDIANA UNIVERSITY INDIANAPOLIS — INDIANAPOLIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WHITE, KENNETH E — INDIANA UNIVERSITY INDIANAPOLIS
- Study coordinator: WHITE, KENNETH E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.